These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33147927)

  • 41. Development and validation of an individualized risk prediction model for oropharynx cancer in the US population.
    Tota JE; Gillison ML; Katki HA; Kahle L; Pickard RK; Xiao W; Jiang B; Graubard BI; Chaturvedi AK
    Cancer; 2019 Dec; 125(24):4407-4416. PubMed ID: 31454434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of two risk-prediction models for recurrent falls in the first year after stroke: a prospective cohort study.
    Walsh ME; Galvin R; Boland F; Williams D; Harbison JA; Murphy S; Collins R; Crowe M; McCabe DJH; Horgan F
    Age Ageing; 2017 Jul; 46(4):642-648. PubMed ID: 28104593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination and calibration of mortality risk prediction models in interventional cardiology.
    Matheny ME; Ohno-Machado L; Resnic FS
    J Biomed Inform; 2005 Oct; 38(5):367-75. PubMed ID: 16198996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Association between body mass index and risk of lung cancer in non-smoking males: a prospective cohort study].
    Xie SH; Wang G; Guo LW; Chen SH; Su K; Li F; Chang S; Feng XS; Lyu ZY; Chen YH; Ren JS; Yin J; Cui H; Wu SL; Dai M; Li N; He J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Sep; 37(9):1213-1219. PubMed ID: 27655565
    [No Abstract]   [Full Text] [Related]  

  • 45. A prediction model for N2 disease in T1 non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
    Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
    JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occult lung cancer manifesting within the first year after stroke.
    Babore AD; Tybjerg AJ; Andersen KK; Olsen TS
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105023. PubMed ID: 32807438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting cardiovascular intensive care unit readmission after cardiac surgery: derivation and validation of the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) cardiovascular intensive care unit clinical prediction model from a registry cohort of 10,799 surgical cases.
    van Diepen S; Graham MM; Nagendran J; Norris CM
    Crit Care; 2014 Nov; 18(6):651. PubMed ID: 25408082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Establishment of the prediction model for ischemic cardiovascular disease of elderly male population under current health care program].
    Chen JH; Wu HY; He KL; He Y; Qin YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1166-9. PubMed ID: 21162823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.
    Wang S; Ogundiran T; Ademola A; Olayiwola OA; Adeoye A; Sofoluwe A; Morhason-Bello I; Odedina S; Agwai I; Adebamowo C; Obajimi M; Ojengbede O; Olopade OI; Huo D
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):636-643. PubMed ID: 29678902
    [No Abstract]   [Full Text] [Related]  

  • 51. Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study.
    Bruyand M; Le Marec F; Lavole A; Leffondre K; Spano JP; Le Moing V; Tattevin P; March L; Cadranel J; Bonnet F; Guiguet M
    AIDS; 2015 Jun; 29(9):1105-9. PubMed ID: 26125142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.
    Tindle HA; Stevenson Duncan M; Greevy RA; Vasan RS; Kundu S; Massion PP; Freiberg MS
    J Natl Cancer Inst; 2018 Nov; 110(11):1201-1207. PubMed ID: 29788259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of a model of lung cancer risk prediction among smokers.
    Cronin KA; Gail MH; Zou Z; Bach PB; Virtamo J; Albanes D
    J Natl Cancer Inst; 2006 May; 98(9):637-40. PubMed ID: 16670389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoking-associated DNA methylation markers predict lung cancer incidence.
    Zhang Y; Elgizouli M; Schöttker B; Holleczek B; Nieters A; Brenner H
    Clin Epigenetics; 2016; 8():127. PubMed ID: 27924164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The development and validation of risk prediction model for lung cancer: a systematic review].
    Lyu ZY; Tan FW; Lin CQ; Li J; Wang YL; Chen HD; Ren JS; Shi JF; Feng XS; Wei LP; Li X; Wen Y; Chen WQ; Dai M; Li N; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Apr; 54(4):430-437. PubMed ID: 32268653
    [No Abstract]   [Full Text] [Related]  

  • 58. Prior lung disease and risk of lung cancer in a large prospective study.
    Littman AJ; Thornquist MD; White E; Jackson LA; Goodman GE; Vaughan TL
    Cancer Causes Control; 2004 Oct; 15(8):819-27. PubMed ID: 15456995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model.
    Zhao H; Marshall HM; Yang IA; Bowman RV; Ayres J; Crossin J; Lau M; Slaughter RE; Redmond S; Passmore L; McCaul E; Courtney D; Leong SC; Windsor M; Zimmerman PV; Fong KM
    Br J Radiol; 2016; 89(1060):20160016. PubMed ID: 26882046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simplified prognostic model for critically ill patients in resource limited settings in South Asia.
    Haniffa R; Mukaka M; Munasinghe SB; De Silva AP; Jayasinghe KSA; Beane A; de Keizer N; Dondorp AM
    Crit Care; 2017 Oct; 21(1):250. PubMed ID: 29041985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.